Dr. Reddy’s Laboratories is becoming synonymous with Form 483s from the FDA: Already knocked four times this year, India’s second-largest drugmaker now has a fifth notice to dwell on. This time, it’s for an oncology plant with a history of faults.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,